Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03864887
Other study ID # Brain Death of AMS
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 11, 2019
Est. completion date December 31, 2019

Study information

Verified date March 2019
Source Chinese Academy of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This study aims to evaluate brain death with optical probes. The changes of hemodynamic parameters including oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) were detected by near infrared spectroscopy probes attached on the forehead of patients. A multiple-phase protocol at varied fraction of inspired O2 were utilized during the assessment.


Description:

Brain death is an irreversible loss of all brain functions, and the assessment is crucial for organ supply for transplantation. The noninvasive, sensitive, universally available and timely ancillary method to assess brain death has not been established. This study aims to evaluate brain death with optical probes. The changes of hemodynamic parameters including oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) were detected by near infrared spectroscopy probes attached on the forehead of patients. A multiple-phase protocol at varied fraction of inspired O2 were utilized during the assessment. The concentration changes ratios of oxyhemoglobin to deoxyhemoglobin (Δ[HbO2]/Δ[Hb]) in the cerebral cortex of brain-dead patients were significantly higher than those of healthy subjects.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date December 31, 2019
Est. primary completion date August 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients who have had brain death or serious brain trauma.

- Healthy people who are interested in optical assessment of hemodynamic parameters

Exclusion Criteria:

- Patients who are in pregnancy or have plan to conception.

- Patients who have vertebra surgery or have plan of surgery.

- Patients who are inappropriate to join this trial judged by the radiologists or specialists.

- AIDS, Active Hepatitis, Tuberculosis, Syphilis

- Patients who regularly take anticoagulants, antiplatelet drugs

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Oxygen supply of high-low-high procedure
The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 60% FIO2 (phase I, high oxygen), half-hour measurement at 40% FIO2 (phase II, low oxygen) and half-hour measurement at 60% FIO2 (phase III, high oxygen).
Oxygen supply of low-high-low procedure
The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 40% FIO2 (phase I, low oxygen), half-hour measurement at 60% FIO2 (phase II, high oxygen) and half-hour measurement at 40% FIO2 (phase III, low oxygen).
Device:
Optical monitor for hemodynamic parameter.
Near infrared spectroscopy probes of tow wavelengths were attached on the subjects' foreheat to detect the changes of hemodynamic parameters.

Locations

Country Name City State
China NIRS assessment for brain death Tianjin Tianjin

Sponsors (1)

Lead Sponsor Collaborator
Chinese Academy of Medical Sciences

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary ?[HbO2] The changes of oxyhemoglobin concentrations in prefrontal cortex. 1 day during the whole experiment
Primary ?[Hb] The changes of deoxyhemoglobin concentrations in prefrontal cortex. 1 day during the whole experiment
Secondary Heart rate Heart rate of patient recorded by bed-side physiological monitor. 1 day during the whole experiment
Secondary Blood pressure Blood pressure of patient recorded by bed-side physiological monitor. 1 day during the whole experiment
See also
  Status Clinical Trial Phase
Recruiting NCT03765814 - The Anticipated Organ Donation Approach
Completed NCT02581111 - Naloxone for Optimizing Hypoxemia Of Lung Donors Phase 2/Phase 3
Completed NCT00808691 - Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit N/A
Completed NCT00998972 - N-acetyl-cysteine (NAC) and Kidney Graft Function Phase 3
Completed NCT04528797 - Thyroid and Adrenocortical Hormone Replacement in Organ Donors N/A
Completed NCT03672812 - The Use of Liraglutide in Brain Death Phase 3
Completed NCT04303624 - Understanding Family Refusal
Completed NCT03098706 - Therapeutic Hypothermia in "Expanded Criteria" Brain-dead Donors and Kidney-graft Function N/A
Not yet recruiting NCT04623294 - Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy
Recruiting NCT02102945 - Special Imaging Technique to Aid in the Diagnosis of Patients in Coma After Cardiac Arrest N/A
Completed NCT02483273 - Alterations of Conjunctival Microcirculation in Brain Dead Patients N/A
Terminated NCT00675272 - Organ Donation and Hydrocortisone Treatment N/A
Completed NCT03262896 - Neurophysiological Examination in Patients With Brain Death
Not yet recruiting NCT06359119 - Implementation of Apnoea Test for Patients With Suspected Brain Death
Recruiting NCT05202886 - "LiverColor": Machine Learning in Liver Photographs N/A
Completed NCT03281993 - Apnea Tests as the Methods of Brain Death Diagnosis. N/A
Completed NCT03179020 - Donation Network to Optimize Organ Recovery Study N/A
Completed NCT05070182 - Resting Energy Needs in Brain Dead Patients (reSting EneRgy nEeds iN brAin DEad Patients)
Terminated NCT03439995 - Goal of Open Lung Ventilation in Donors N/A
Completed NCT02525510 - Deceased Organ Donor Interventions to Protect Kidney Graft Function N/A